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Zfhx1bThe involvement of SOX10 and ZFHX1B in Waardenburg–Hirschsprung disease (hypopigmentation, deafness,
and absence of enteric ganglia) and Mowat–Wilson syndrome (mental retardation, facial dysmorphy and
variable congenital malformations including Hirschsprung disease) respectively, highlighted the importance
of both transcription factors during enteric nervous system (ENS) development. The expression and function
of SOX10 are now well established, but those of ZFHX1B remain elusive. Here we describe the expression
proﬁle of Zfhx1b and its genetic interactions with Sox10 during mouse ENS development. Through phenotype
analysis of Sox10;Zfhx1b double mutants, we show that a coordinated and balanced interaction between
these two genes is required for normal ENS development. Double mutants present with more severe ENS
defects due to decreased proliferation of enteric progenitors and increased neuronal differentiation from
E11.5 onwards. Thus, joint activity between these two transcription factors is crucial for proper ENS
development and our results contribute to the understanding of the molecular basis of ENS defects observed
both in mutant mouse models and in patients carrying SOX10 and ZFHX1B mutations.pital Henri Mondor, 51 Avenue
e. Fax: +33 148993345.
ndurand).
x 2, B-3001 Leuven, Belgium.
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The enteric nervous system (ENS) is the part of the peripheral
nervous system that controls the peristaltic and secretory activity of
the gut wall (Gershon et al., 1994). It is composed of a large number of
neurons and glial cells, which are organized into interconnected
ganglia distributed throughout the length of the gut (Burns and
Thapar, 2006; Furness, 2006; Hao and Young, 2009; Heanue and
Pachnis, 2007). During embryogenesis, most of the ENS is derived
from the vagal neural crest cells (Le Douarin and Kalcheim, 1999). A
small portion also derives from the sacral region (Burns and Douarin,
1998). After delaminating from the neural tube, vagal neural crest
cells enter the foregut at day E9.5 in mice and, migrating in a
rostrocaudal direction, colonize the entire length of the gut by E15.
Altered proliferation, survival, migration or differentiation of ENCC
(Enteric Neural Crest Cells) result in an absence of enteric ganglia
(aganglionosis), usually affecting the colon, and leading to severeconstipation or intestinal obstruction (Hirschsprung disease, HSCR)
(for review see (Amiel et al., 2008; Heanue and Pachnis, 2007).
Studies performed so far led to the identiﬁcation of critical players in
ENS development, including the Receptor Tyrosine Kinase RET, its
ligands GDNF and NTN, the G-coupled receptor EDNRB and its ligand
endothelin-3, the BMP signaling pathway, KBP, β1 integrin and L1-
CAM adhesion molecules, and the transcription factors PHOX2B,
MASH1, HAND2, ZFHX1B and SOX10 (for review see (Amiel et al.,
2008; Burns and Thapar, 2006; Burzynski et al., 2009; Hao and Young,
2009; Heanue and Pachnis, 2007).
SOX10 is amember of the high-mobility group-domain SOX family
of transcription factors (for review, see (Bowles et al., 2000; Kelsh,
2006; Mollaaghababa and Pavan, 2003; Wegner, 1999; Wegner, 2005,
2009; Wilson and Koopman, 2002). In 1998, cloning and involvement
of this gene in a spontaneous mouse model of Waardenburg–
Hirschsprung disease (the Dom mouse presenting with hypopigmen-
tation, deafness, and absence of enteric ganglia) showed its crucial
role for proper neural crest cells development, and ENS and
melanocytes in particular (Herbarth et al., 1998; Southard-Smith et
al., 1998). Invalidation of this gene by targeted gene deletion
conﬁrmed these observations (Britsch et al., 2001). Indeed, at the
heterozygous state, bothmousemutants exhibit pigmentation defects
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Homozygous mutant mice on the other hand have severe deﬁcits in
several neural crest derivatives, including complete lack of ENS
(Britsch et al., 2001; Herbarth et al., 1998; Kapur, 1999; Southard-
Smith et al., 1998).
Duringmouse development, Sox10 is ﬁrst expressed in neural crest
cells, including cells of vagal origin, as they delaminate from the
neural tube. At this stage, SOX10 protein appears to be required for
the survival and the maintenance of these cells prior to lineage
segregation (Honore et al., 2003; Kapur, 1999; Kim et al., 2003).When
they enter the foregut, all ENCC express Sox10, which is considered a
marker of ENS progenitors (for review, see (Heanue and Pachnis,
2007)). In partial absence of Sox10, mice possess a smaller pool of ENS
progenitors, strongly suggesting a role for this HMG-type transcrip-
tion factor in maintaining progenitor state (Paratore et al., 2002).
Later, Sox10 is expressed in glial cells but switched off in neurons
(Bondurand et al., 2003; Young et al., 2003), and it is proposed to
function in cell fate speciﬁcation and glial cell differentiation (for
review, see (Heanue and Pachnis, 2007)). Extinction of this gene
seems to be a prerequisite for complete neuronal differentiation.
Consistent with these observations, constitutive expression of Sox10
inhibits overt neuronal differentiation in cultured ENCC (Bondurand
et al., 2006).
An increasing number of molecular and developmental studies
revealed that interactions between SOX10 and other pathways are
crucial for proper ENS development. Genome-wide association
studies performed in mice as well as phenotypic analysis of mouse
double mutants revealed interactions between Sox10 and loci located
on chromosomes 3, 5, 8, 11 and 14 as well as with Sox8, Ret, and
endothelin-3/Ednrb (Cantrell et al., 2004; Lang et al., 2000; Maka et al.,
2005; Owens et al., 2005; Stanchina et al., 2006; Zhu et al., 2004). It
now seems crucial to expand this gene network and identify which
other factors could interact with Sox10, thus controlling multi-lineage
ENS progenitor maintenance and enteric differentiation.
ZFHX1B (Zinc Finger HomeoboX 1b; also known as ZEB2, Zinc
ﬁnger E-box Binding homeobox 2 or SIP1, Smad Interacting Protein 1)
belongs to the Zfhx1 family proteins in vertebrates. Originally
described as transcriptional repressors, these transcription factors
are characterized by a homeodomain-like domain and two separated
clusters of multiple zinc ﬁngers (Postigo and Dean, 2000; van
Grunsven et al., 2001; Verschueren et al., 1999). ZFHX1B was
identiﬁed in a yeast two-hybrid screen as a protein binding to the
MH2 domain of Smad1 (Verschueren et al., 1999) and is therefore a
candidate component of the signal transduction pathways triggered
by the Smad effector proteins of the TGF-β/BMP family (Eisaki et al.,
2000; Postigo, 2003; van Grunsven et al., 2001). Numerous studies
have shown that it is involved in neural speciﬁcation where it has
been proposed to transcriptionally inhibit BMP production (Eisaki et
al., 2000; Nitta et al., 2007, 2004; Van de Putte et al., 2003; van
Grunsven et al., 2007). Recent studies in Xenopus have shown that
XSIP1 binds directly to the proximal promoter of Bmp4 and represses
expression of this gene (van Grunsven et al., 2007). ZFHX1B has also
been shown to play an important role in epithelial–mesenchymal
transition (EMT) by repressing several adhesion molecules including
E-cadherin (Comijn et al., 2001; van Grunsven et al., 2003;
Vandewalle et al., 2005).
The role of ZFHX1B in ENS development was ﬁrst highlighted by its
involvement in Mowat–Wilson syndrome, a dysmorphic and severe
mental retardation syndrome with occurrence of Hirschsprung
disease or constipation (Cacheux et al., 2001; Dastot-Le Moal et al.,
2007; Garavelli et al., 2009; Wakamatsu et al., 2001; Zweier et al.,
2005). Generation of Sip1/Zfhx1b/Zeb2 knock-out mice revealed that
it is essential for speciﬁcation of sufﬁcient numbers of vagal neural
crest cells (Higashi et al., 2002; Van de Putte et al., 2003).
Heterozygous animals present with no apparent gross morphological
defects except an absence of corpus callosum, but homozygotes die atE9.5 and present with cardiovascular dysfunction, an aberrant neural
plate, failure of the neural tube to close, and shortened somites. More
importantly, Zfhx1b homozygous embryos show a delay in cranial
neural crest migration and the near-absence of vagal neural crest
formation (Van de Putte et al., 2003). Recently, a conditional knock-
out has been generated in which Zfhx1b was speciﬁcally removed in
neural crest cells using a Wnt1-Cre crossing strategy. Homozygous
mice present with speciﬁc abnormalities in craniofacial, heart,
melanocytes and peripheral nervous system development as well as
severe intestinal aganglionosis (Van de Putte et al., 2007). In human,
mice and zebraﬁsh, preliminary expression studies revealed the
presence of Zfhx1b within vagal enteric precursor cells upon gut
invasion. Later during development, the whole ENS is heavily
expressing this factor (Bassez et al., 2004; Delalande et al., 2008;
Espinosa-Parrilla et al., 2002; Van de Putte et al., 2007). However, the
spatio-temporal expression proﬁle and function of ZFHX1B during
ENS development and differentiation as well as its interaction with
other ENS factors remain poorly studied.
Here we analyzed the expression of Zfhx1b and explored the
possibility of genetic interactions between this gene and Sox10 during
ENS development. To this end, we crossed the conventional Zfhx1b
mutant with the Sox10 knock-out mouse, compared the enteric
phenotype of single and double heterozygous animals, and investi-
gated the cellular origin of the observed ENS defects.
Materials and methods
Animals, pups, embryos collection and genotyping
The generation of Sox10LacZ and Zfhx1bΔex7 animals have been
described previously (Britsch et al., 2001; Higashi et al., 2002; Van de
Putte et al., 2003). Sox10LacZ mice were backcrossed on C3HeB/FeJ for
at least 4 generations before use. Zfhx1bΔex7 were generated and
maintained on CD1 background. Alternatively, Zfhx1bΔex7 were
crossed on C3HeB/FeJ background. Similar results were obtained
whatever the genetic background used. The genotype of mice and
embryos was determined by PCR analysis of genomic DNA extracted
from a tail tip fragment or yolk sac, respectively using PCR primers
previously described (Britsch et al., 2001; Van de Putte et al., 2007),
except for Zfhx1b-intron6R which was modiﬁed as follows: 5′-
ATCAGCAGCCTCCTATTTAAACAGAGTGTC-3′. Zfhx1bΔ/+ mice were
crossed with Sox10LacZ/+ to generate embryos and pups. Embryos
from E9.5 to E15.5 were obtained from staged pregnancies. The day of
vaginal plug was considered to be E0.5.
Dissected guts or embryos were ﬁxed one to two hours in 4%
paraformaldehyde at 4 °C. After ﬁxation, 8 μm frozen sections of
embryos of different genotypes were generated. Dissected guts or
sections were used for immunohistochemistry. Alternatively, whole
embryos or dissected guts were ﬁxed in 1% paraformaldehyde and
0.2% glutaraldehyde and used for whole-mount X-Gal staining.
Acute cultures
Acute cultures of guts were performed as described (Barlow et al.,
2003). Brieﬂy, guts were dissected from E11.5 or E13.5 embryos of
different genotypes, stomach region was removed and intestine was
incubated with dispase/collagenase (0.5 mg/ml in PBS1X, Roche) for
5 min at room temperature. Digested tissues were washed twice with
1× PBS, dissociated by repeated pipetting, and plated on ﬁbronectin
coated (20 μg/ml) SONIC-SEAL wells (VWR) in optiMEM (Life
technologies). After a few hours in an atmosphere of 5% CO2, most
cells were adherent and no differential cell adherence was observed
between the genotypes as assessed by counting the number of cells
before and after plating (DAPI staining). Cultures were ﬁxed 10 min in
4% paraformaldehyde at 4 °C, and used for immunohistochemistry.
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Immunostainingwas performedas previously described (Barlowet
al., 2003; Bondurand et al., 2003). The following primary antibodies
were used in various combinations: TuJ1 (mouse, 1:1000 dilution,
Eurogentec), phospho-histone 3 (PH3, rabbit, 1:500 dilution, Upstate),
activated-Caspase-3 (casp3, rabbit, 1:200 dilution, Cell Signaling),
Sox10 (rabbit, 1:200 dilution, Chemicon), Sox10 (guinea pig, 1:500
dilution, kindly provided by Dr. M. Wegner; (Maka et al., 2005)),
Phox2b (rabbit, 1:500 dilution, kindly provided by Dr. J.F. Brunet;
(Pattyn et al., 1997)), B-FABP (rabbit, 1:5000 dilution, kindly provided
by Dr. T. Müller; (Kurtz et al., 1994)), GFAP (Rabbit, 1:400 dilution,
Dakocytomation), and Zfhx1b (rabbit; 1:50; kindly provided by D.
Huylebroeck; (Seuntjens et al., 2009)). Secondary antibodies used
were as follows: anti-mouse FITC conjugated (1:150 dilution, Sigma),
anti-mouse alexaFluor568 (1:500 dilution, Invitrogen), anti-rabbit
FITC conjugated (1:150 dilution, Sigma), anti-rabbit Cy3 (1:150
dilution, Sigma), and anti-guinea pig Cy3 (1:200 dilution, Dianova).
Preparations were mounted directly in Vectashield containing DAPI
(Vector laboratories). X-Gal staining followed standard procedures.
Sections, guts or cultureswere examinedwith a LeicaDMRmicroscope
equipped with a Hamamatsu digital camera or Olympus SZH10 and
Leica MZ6 stereo microscope coupled to Visilog capture program.
Results
Zfhx1b expression in progenitor and glial cells during ENS development
To gain insight into ZFHX1B function during ENS development, we
ﬁrst compared its expression pattern to that of SOX10. To this end, we
performed co-immunohistochemistry with antibodies against Zfhx1b
and Sox10, TuJ1 or GFAP on wild-type embryos sections from E9.5 to
birth. We observed that ZFHX1B was present in all SOX10-positive
vagal crest cells from E9.5 onwards. Indeed, at E9.5/E10, double
labeled Sox10/Zfhx1b cells were found closely apposed to the lateral
and ventral part of the dorsal aorta as well as entering the foregut
(Fig. 1 A and inserts A1 to A3). Later during development, ZFHX1B
protein is found in almost all SOX10-positive cells within enteric
ganglia (Fig. 1 B, D and inserts B1–3 and D1–3). Upon differentiation,
ZFHX1B protein is downregulated in neuronal cells. Indeed, it is
absent from cells expressing the neuron speciﬁc class III β-tubulin
(identiﬁed by TuJ1 antibody; Fig. 1 C, E and inserts C1–3 and E1–3). In
contrast, it is present in ENCC acquiring a glial cell fate (GFAP-
expressing cells, Fig. 1 F and G and inserts F1–3, G1–3). Altogether
these results suggest that ZFHX1B, similar to SOX10, is present in
enteric progenitors and glia as ENS development proceeds, but is
switched off in neurons. Interestingly, sections across the stomach
region performed at E13.5 revealed that ZFHX1B is not restricted to
ENCC and glial derivatives. It is also found in mesenchymal cells
adjacent to the epithelium, in a region previously described as
containing BMP4-expressing cells (Fu et al., 2006).
Genetic interactions between Sox10 and Zfhx1b during ENS development
The overlap between SOX10 and ZFHX1B expression proﬁles led us
to speculate that both factors could control various steps of ENCC in an
additive or cooperative manner. To test the possibility of a genetic
interaction between both loci, we exploited the availability of mice
with targeted mutation within each of these genes (for detailsFig. 1. Zfhx1b proﬁle during ENS development. (A) Zfhx1b (Green)/Sox10 (Red) double imm
magniﬁcations of the boxed region in A and show that Zfhx1b and Sox10 co-localize in most v
region. (B, C) Immunostaining on sections through the stomach of E10.5/E11.5 and (D, E, F
Zfhx1b staining in the nuclei of Sox10 undifferentiated ENCC (B and D), presence of Zfhx1b
(G) Immunostaining on sections through the intestine of adult mice using anti-Zfhx1b and
indicate the stomach lumen. Inserts B1–3, C1–3, D1–3, E1–3, F1–3, G1–3 represent higher m
cells adjacent to the stomach epithelium at E13.5 (D–F).regarding mouse models, see Materials and methods). We crossed
Sox10 and Zfhx1b heterozygous mice and compared the enteric
phenotype of single and double heterozygous mice. As distribution of
enteric neurons along the gut reﬂects the progress of migration and
differentiation of ENCC, we ﬁrst compared neurogenesis in the gut of
embryos of different genotypes using whole-mount immunostaining
with TuJ1, an appropriatemarker to visualize complete colonization of
the gut in wild-type mouse embryos at E13.5 (Barlow et al., 2003;
Stanchina et al., 2006).
Consistent with previous ﬁndings, we observed no signiﬁcant
difference in the intensity or distribution of staining between wild-
type and Zfhx1b heterozygous guts (Fig. 2, compare panels A1–5 with
B1–5). In contrast, we observed a migration delay in the majority of
Sox10LacZ/+ single mutants (Fig. 2 C1–5). TuJ1-positive cells were
missing from the caecum onwards in 2/3rd of the guts analyzed
(Fig. 2 E). More importantly, all guts from Sox10LacZ/+;Zfhx1bΔ/+
showed a severe colonization delay compared to single mutants.
Indeed, TuJ1 staining stopped within the ﬁrst half of the small
intestine in 4 out of 7 guts, or before the caecum entry in 3 out of 7
guts (Fig. 2 D1–5 and E). Interestingly, complete disorganization of
the neuronal network was also clearly visible in colonized regions of
all double heterozygous guts (e.g., see the reduction in the number of
neurons and the enhanced ganglion cell aggregation observed in
Fig. 2 G; compare to F). Thus, removal of one Zfhx1b allele in Sox10
heterozygous animals results in an ENS phenotype that is much more
severe than that of single mutants, conﬁrming a strong genetic
interaction between these two genes during ENS development.
To determine whether the observed defects reﬂect the absence of
enteric progenitor cells expressing Sox10 or defects in neuronal
differentiation, we took advantage of the LacZ reporter present in the
Sox10LacZ allele and performed staining with X-Gal on whole-mount
gut preparations. When staining of Sox10LacZ/+;Zfhx1bΔ/+ guts was
compared to that of Sox10LacZ/+, a strong colonization delay was
observed in all cases (compare Fig. 3 A with B). Indeed, staining
stopped halfway through the small intestine of the 6 double
heterozygous embryos that were analyzed. In contrast, Sox10LacZ/+
littermates presented with no defects or with an absence of staining,
which is limited to the second half of the caecum and/or the colon.
The enteric defects observed in Sox10LacZ/+;Zfhx1bΔ/+ therefore
result from the absence of enteric progenitor cells along a variable
length of the intestine. A complete disorganization of the enteric
network was also clearly visible within colonized regions of double
mutants (compare A1 and B1), similar to the respective patterns
observed via staining for TuJ1.
Absence of ENS defects in E9.5/E10 embryos with Sox10 and Zfhx1b
deﬁciencies
To determine the origin of the ENS defects, we extended our
analyses to earlier time points, and ﬁrst compared the behavior of
vagal neural crest cells around the time of foregut invasion (from E9.5
to E10.5). X-Gal staining performed on whole-mount embryos
revealed no apparent defects in double heterozygous embryos as
compared to Sox10LacZ/+ littermates (Fig. 4 A and data not shown).
Indeed, ENCC were found to migrate within the foregut of all E9.5 and
E10.5 embryos analyzed, in a very similar pattern (compare Fig. 4 A6
to A5, and data not shown). For example, at E10.5, and irrespective of
the genotypes of the respective embryos, cells were visualized within
the stomach region and migrated in chain to colonize the smallunostaining of sections of E9.5/E10 wild-type embryos. Inserts A1–3 represent higher
agal neural crest cells upon gut colonization. The white dotted lines indicate the foregut
) E13.5 embryos using anti-Zfhx1b, Sox10, TuJ1 and GFAP antibodies revealed a strong
in GFAP+glial cells (F), and a downregulation of Zfhx1b in TuJ1+ neuronal cells (C, E).
GFAP antibodies conﬁrm Zfhx1b presence in glial cells. Dotted lines in B, C, D, E, F, G
agniﬁcations of B to G, respectively. Note also the presence of Zfhx1b in mesenchymal
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Fig. 2. Genetic interaction between Sox10 and Zfhx1b controls ENS development. Whole-mount TuJ1 immunohistochemistry was performed on E13.5 guts from wild-type (A1–5),
Zfhx1bΔ/+ (B1–5), Sox10LacZ/+ (C1–5) and Sox10LacZ/+;Zfhx1bΔ/+ (D1–5) embryos. Panels A1 to D1, A2 to D2, A3 to D3, A4 to D4, A5 to D5 show staining in the distal stomach, the
ﬁrst part and middle of the small intestine, the caecum and the colon, respectively. (E) Schematic representation of the gut. The shaded areas on top of this scheme represent the
regions of the gut shown in A to D. Below this scheme, the lines and perpendicular arrows indicate the extent of colonization for each class of genotyped embryos. The number of
embryos presenting with a deﬁned defect are indicated on the left of each arrow. Note the severe delay in colonization in double heterozygous animals (D1–5 and E) compared to the
respective single mutants (B1–5 and C1–5 and E). F and G represent higher magniﬁcations of C2 and D2 respectively. Note the disorganized network of neurons observed in G. s:
stomach; si: small intestine; ce: caecum; co: colon.
420 L. Stanchina et al. / Developmental Biology 341 (2010) 416–428intestine (Fig. 4 A). Interestingly, X-Gal staining performed on E10.5
embryos revealed no apparent defects in other neural crest deriva-
tives either. Indeed, general observation of cranial ganglia, dorsal root
ganglia and peripheral nerves revealed no differences between
Sox10LacZ/+ and Sox10LacZ/+;Zfhx1bΔ/+ embryos (compare Fig. 4 A2
to A1 and A4 to A3).To complete these observations, we labeled sections of E9.5
embryos of different genotypes with anti-Sox10 antibody to compare
the number of vagal neural crest cells invading the foregut region and
with activated-Caspase-3 to document apoptosis within and outside
of the gut (Fig. 4 B). In sections of wild-type embryos, as well as of
Zfhx1bΔ/+, an apparent equal number of cells were observed that
Fig. 3. ENSphenotype in double heterozygousmice results froman absence of enteric progenitor cells.Whole-mount X-Gal stainingwas performed on E13.5–14 guts fromSox10LacZ/+
(A) and Sox10LacZ/+;Zfhx1bΔ/+ (B) embryos. Note the absence of X-Gal staining halfway through the small intestine of Sox10LacZ/+;Zfhx1bΔ/+ embryos. s: stomach. Ce: caecum. A1
and B1 represent higher magniﬁcations of boxed regions in A and B. Note the reduced number of cells and disorganized network in Sox10LacZ/+;Zfhx1bΔ/+ embryos.
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detected (Fig. 4 B1 to B4). As previously described, we observed few
apoptotic cells in the stream of migrating ENCC in Sox10LacZ/+ (Fig. 4
B5–6 and (Maka et al., 2005; Stanchina et al., 2006). We made similar
observations when Sox10LacZ/+;Zfhx1bΔ/+ mutants were analyzed,
but the number of Sox10-positive migrating cells was comparable to
that observed in wild-type embryos (Fig. 4 B7–8 and data not shown).
Taken together, these results clearly show that ENCC migration in
double heterozygous mouse embryos is not altered up to E10.5. The
ENS defects observed in such mutant mice are thus neither due to
increased cell death nor abnormal migration of vagal neural crest cells
prior or at the time of foregut invasion.
Sox10;Zfhx1b double heterozygous embryos show severe but restricted
ENS defects at E11.5
We then extended our analysis beyond these time points and
analyzed the enteric phenotype of embryos of different genotypes
only one day later. X-Gal staining performed on whole-mount
embryos as well as TuJ1 staining performed on E11.5 whole-mount
gut preparations revealed an apparent normal pattern of ENCC
migration or a slight delay in Zfhx1bΔ/+ or Sox10LacZ/+ embryos
compared to wild-type embryos. Indeed, the vast majority of single
heterozygous mice presented with cells in the stomach, the small
intestine, and the wavefront of migrating ENCC was seen entering the
caecum area (See Fig. 5 A3 and data not shown). In contrast, we
observed a dramatic reduction in the number of X-Gal and TuJ1-
positive cells in the gut of Sox10LacZ/+;Zfhx1bΔ/+embryos. Indeed, the
wavefront of migrating ENCC seemed severely delayed in all double
heterozygous embryos analyzed (n=6, compare Fig. 5 A4 to A3 and
data not shown; note that 2 out of 6 embryos presented with X-Gal-
positive cells up to 3/4th of the small intestine, whereas 4 out of the 6
embryos presented with positive cells up to 1/3rd or halfway through
the small intestine only). In agreement with observations made at
E13.5, a complete disorganization of the network was also clearly
visible in colonized regions of all E11.5 double heterozygous embryos
(see the reduction in the number of X-Gal-positive cells in the inserts
of panels A4; compare to A3). Thus, a severe ENS phenotype is seen
from E11.5 onwards. At that stage, cells seem to be able to reach thestomach but fail to colonize the vast majority of the small intestine
and more distal parts of the gastrointestinal tract.
Similar to E10.5 results, X-Gal staining revealed no apparent
defects of other neural crest derivatives at E11.5. Indeed, general
observation revealed no abnormal formation of cranial ganglia, dorsal
root ganglia (DRG) or peripheral nerves in Sox10LacZ/+;Zfhx1bΔ/+
embryos compared to Sox10LacZ/+ littermates (compare Fig. 5 A2 to
A1). The presence and the function of ZFHX1B and SOX10 in
melanocytes and glial cells of the peripheral nervous system (Britsch
et al., 2001; Van de Putte et al., 2007;Wegner, 2005) also prompted us
to examine the formation of these derivatives in E11.5 Sox10LacZ/+;
Zfhx1bΔ/+ embryos. Taking advantage of the LacZ reporter within the
Sox10LacZ allele, we ﬁrst observed migration of melanoblasts.
Irrespective of the genotypes, migrating melanoblasts were seen in
the head (compare Fig. 5 B2 to B1), the cranial region (compare B4 to
B3) and reaching the base of the hindlimb (compare B6 to B5),
suggesting no apparent defects in double heterozygous embryos. In
parallel, sections of E11.5 wild-types, single and double heterozygous
embryos were labeled with anti-TuJ1 and anti-B-FABP (brain-speciﬁc
fatty acid binding protein) antibodies in order to visualize neurons
and glial cells, respectively, in DRG and along spinal nerves. B-FABP-
positive cells were abundant in both areas in all embryos, suggesting
normal glial cell differentiation in double mutants and single mutants
(compare Fig. 5 C4 to C1–3). The phenotype of embryos with
combined Sox10;Zfhx1b mutations thus suggests a speciﬁc coopera-
tive requirement of both factors during ENS development only.
Cellular mechanism at the origin of the ENS defects observed in E11.5
and E13.5 embryos with Sox10 and Zfhx1b deﬁciencies
To determine the cellular defects underlying the ENS phenotypes
observed in E11.5 and E13.5 Sox10LacZ/+;Zfhx1bΔ/+ embryos, we
quantiﬁed the pool of enteric progenitor cells and analyzed their
proliferation and differentiation capacities.
We ﬁrst quantiﬁed the number of progenitor cells on cultures of
acutely dissociated guts at E11.5 by counting Phox2b-positive cells
(which identiﬁes ENCC progenitors and derivatives (Young et al.,
2003)) and the fraction of these that were co-labeled with Sox10
(which identiﬁes progenitor cells at that stage). In agreementwith the
Fig. 4. Absence of ENS defects in Sox10;Zfhx1b double heterozygousmutant embryos at E10–E10.5. (A)Whole-mount X-Gal staining of E10.5 Sox10LacZ/+ and Sox10LacZ/+;Zfhx1bΔ/+
embryos. A3 and A4 represent higher magniﬁcations of A1 and A2, respectively. A5 and A6 panels have been obtained after dissection of the gut, allowing better visualization of ENCC
migration along the foregut. Note the absence of defects in Sox10LacZ/+;Zfhx1bΔ/+ at this stage. s: stomach. ce: caecum (B) Scheme of the area shown in B1 to B8. (B1–8)
Immunohistochemistry on sections of E10 wild-type (B1–2), Zfhx1bΔ/+ (B3–4), Sox10LacZ/+ (B5–6), and Sox10LacZ/+;Zfhx1bΔ/+ (B7–8) embryos, using anti-Sox10 (Red) and anti-
Caspase-3 (Green) antibodies. White dotted lines indicate the esophagus tracheal (B1, 3, 5, 7) and foregut (B2, 4, 6, 8) regions. Note the absence of apoptosis and normal number of
vagal crest cells in Sox10LacZ/+;Zfhx1bΔ/+ at this stage.
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decrease in the number of Sox10-positive cells in Sox10LacZ/+;
Zfhx1bΔ/+ embryos compared to controls (Fig. 6 A). Indeed, the
percentage of Sox10-positive cells among the Phox2b population in
wild-type, Zfhx1bΔ/+, Sox10LacZ/+ or Sox10LacZ/+;Zfhx1bΔ/+ cultures
were 23±7%, 15±4%, 14±6% and 6±3% respectively (with p values
ranging from 0.0058 to 0.038 when Sox10LacZ/+;Zfhx1bΔ/+ cultures
were compared to wild-types or Sox10LacZ/+ littermates). This
reduction of enteric progenitor cells is therefore likely to contribute
to the more severe ENS phenotype observed in the double
heterozygous mutants.
We next attempted to quantify the proliferation capacities of these
enteric progenitor cells by counting the fraction of Sox10-positivecells that co-labeled with the proliferation marker phospho-histone3.
A signiﬁcant decrease in proliferation was observed in double
heterozygous mutants compared to controls (Fig. 6 B), thus
demonstrating that the observed reduction in the pool of Sox10-
positive cells is at least partially due to a reduction in the proliferation
capacities of these cells.
Finally, we examined the possibility that the absence of ENCC
halfway through the small intestine of double heterozygous mutants
as well as the disorganized network observed in colonized regions
could result from increased differentiation. We ﬁrst analyzed the
overall neuronal differentiation in E11.5 and E13.5 embryos of
different genotypes (see Fig. 6 C and D, respectively). To this end,
we determined the fraction of Phox2b population that co-labeledwith
Fig. 5. Phenotype of E11.5 Sox10;Zfhx1b double heterozygous embryos. (A)Whole-mount X-Gal staining of mouse embryonic guts of the indicated genotype. A3 and A4 panels have
been obtained after dissection of the guts, allowing better visualization of ENCC. The inserts in panels A3 and A4 represent higher magniﬁcation of boxed regions. Note the severe ENS
migration delay in Sox10LacZ/+;Zfhx1bΔ/+ (compare A3 to A4), the reduced number of cells, and the disorganized network in Sox10LacZ/+;Zfhx1bΔ/+ embryos (compare insets in A3
and A4). s: stomach; ce: caecum (B) Melanoblasts in E11.5 Sox10LacZ/+ and Sox10LacZ/+;Zfhx1bΔ/+ embryos. X-Gal staining was used to visualize presence of melanoblasts in the
head (B1–2), cranial (B3–4) and tail (B5–6) regions, respectively. Note the presence of migrating melanoblasts in Sox10LacZ/+;Zfhx1bΔ/+ embryos. e: eye; ot: otic vesicle; hl:
hindlimb. (C) Immunohistochemistry in transversal sections (neural tube and DRG region) of E11.5 embryos of indicated genotype using anti-TuJ1 (Red) and anti-B-FABP (Green)
antibodies. Note the absence of gross DRG anomalies (compare A1 to A2; and C4 to C1–3).
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percentage of double-positive (Phox2b+TuJ1+) cells between wild-
type and single mutant embryos. However, a slight but signiﬁcant
increase in overall neuronal differentiation was observed in double
heterozygous mutants. Indeed, an increase of about 15%was observed
in these mutant embryos compared to controls at both stages (with
p values ranging from 0.0054 to 0.017 when E11.5 Sox10LacZ/+;
Zfhx1bΔ/+ were compared to wild-type or Zfhx1bΔ/+ littermates).
Careful analysis of TuJ1 staining at E11.5 allowed us to identify two
types of TuJ1-positive cell population (see also (Stanchina et al.,
2006)). One of these expresses a high level of TuJ1 and has long axonal
processes (Fig. 6 E1); it is likely to correspond to post-mitotic neurons.
The second population expresses a lower level of TuJ1, displays no
axonal processes, and is likely to correspond to committed enteric
neuroblasts (Fig. 6 E2). To quantify the two cell populations, wedetermined the percentage of “TuJ1-High” cells among the total
population of neurons at E11.5. No signiﬁcant difference in the relative
proportion of these cells was observed between wild-type and single
mutant embryos (Fig. 6 F). Indeed, the percentage of “TuJ1-High” among
the total TuJ1 population in wild-type, Zfhx1bΔ/+, and Sox10LacZ/+
cultures were 35±7%, 37±3% and 48±10% respectively (with p
values ranging from p=0.74 to 0.067). In contrast, we found a very
signiﬁcant increase in the relative proportion of “TuJ1-High” cells in
double heterozygous mutants. Indeed, the percentage of “TuJ1-High”
population reached 65±7% in Sox10LacZ/+;Zfhx1bΔ/+ (p ranging from
0.0005 to 0.031 when Sox10LacZ/+;Zfhx1bΔ/+ embryos were compared
to wild-type or Sox10LacZ/+ littermates). Altogether, these results show
that overall neuronal differentiation and/or terminal differentiation is
increased in double heterozygous mutants. This increase could reduce
the migration capacities of ENCC along the gut, and thus explains in part
Fig. 6. Cellular origin of the ENS defects in E11.5 and E13.5 Sox10;Zfhx1b double mutants. (A) The pool of progenitor cells was quantiﬁed by counting the fraction of Phox2b positive
cells co-labeled with Sox10 in acute dissociated gut cultures of E11.5 embryos of different genotypes. On average, 200 to 400 cells from 4 different embryos of each genotype were
counted. Differences to the wild-type were statistically signiﬁcant for Sox10LacZ/+;Zfhx1bΔ/+ (p=0.0058). (B) Proliferation capacities of E11.5 enteric progenitor cells were
quantiﬁed by counting the fraction of Sox10-positive cells co-labeled with phospho-histone 3. On average, 100 to 500 cells from 4 different embryos of each genotype were counted.
Note the signiﬁcant increased proliferation in Sox10LacZ/+;Zfhx1bΔ/+ compared to controls (p=0.006). (C–D) Neuronal differentiation was quantiﬁed by counting the fraction of
Phox2b positive cells co-labeled with TuJ1, reﬂecting the overall neuronal differentiation at E11.5 (C) and E13.5 (D). On average, 300 to 800 cells from 3 to 5 different embryos of each
genotype were counted. Differences to the wild-type were statistically signiﬁcant for Sox10LacZ/+;Zfhx1bΔ/+ at both stages as determined by the Student's test (p=0.0054 and 0.04,
respectively). (E) Careful examination of TuJ1 staining in E11.5 cultures revealed two types of TuJ1 cell population. One of these contains high levels of TuJ1 and has long axons
(“TuJ1-High”, E1). The second population expresses lower levels and has very few short axons (“TuJ1-Low”, E2). (F) Quantiﬁcation of “TuJ1-High” cells over the total population of
TuJ1 positive cells in embryos of each genotype. Note the signiﬁcant increased percentage of “TuJ1-High” cells in Sox10LacZ/+;Zfhx1bΔ/+ compared to controls (wild-type,
p=0.0005; and singlemutants, pb0.04). (G) Quantiﬁcation of the fraction of Sox10-positive cells co-labeled with the early B-FABPmarker, reﬂecting glial differentiation at E13.5. On
average, 200 cells from 5 different embryos of each genotype were counted. Differences with the wild-type embryo were not statistically signiﬁcant (p=0.184).
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mutants.
In parallel, we quantiﬁed the percentage of E13.5 ENCC speciﬁed to a
glial fate by counting the percentage of Sox10-positive cells co-labeled
with B-FABP. No signiﬁcant change in the percentage of double-positive
cells was observed in double heterozygous mutants compared to
controls (Fig. 6 G), indicating that the deletion of one Zfhx1b allele in
Sox10 heterozygous mice does not affect glial cell differentiation.Increased postnatal mortality of Sox10;Zfhx1b double mutants
In order to see if ENS defects observed in Sox10LacZ/+;Zfhx1bΔ/+
embryos could be compensated beyond E13.5,weﬁnally performedX-
Gal staining on P5 guts from Sox10LacZ/+;Zfhx1bΔ/+ and Sox10LacZ/+
animals (Fig. 7). In parallel, we examined the postnatal survival of
animals of different genotypes (Table 1). To this end, we intercrossed
Sox10LacZ/+ and Zfhx1bΔ/+ single mutants and analyzed, within the
Fig. 7. Phenotypic analysis of newborn mice with combined Sox10 and Zfhx1b mutations. Whole-mount X-Gal staining of Sox10LacZ/+ (A) and Sox10LacZ/+;Zfhx1bΔ/+ (B) P5 guts. C
represents a highermagniﬁcation of B showing ganglionic and aganglionic regions. s: stomach; ce: caecum.White arrowhead indicates the transition from stenotic to dilated gut segment.
425L. Stanchina et al. / Developmental Biology 341 (2010) 416–428progeny, themortality of animals of each genotype up to 6 weeks after
birth. At birth, all genotypes were represented in the expected
Mendelian ratio. As previously reported, 92% of Sox10LacZ/+ and all
Zfhx1bΔ/+ survived up to 6 weeks of age and presented without
enteric defects (Fig. 7 A and Table 1). In contrast, 70% of double
heterozygous mice died within the ﬁrst 4 weeks, and none survived
after 6 weeks (Table 1). X-Gal staining at P5 conﬁrmed the presence of
ENS defects in all double mutants analyzed. The aganglionic segment
often extended beyond the caecum and affected the ﬁrst 1/3rd
segment of the small intestine (2 animals analyzed, Fig. 7 B and C). As a
consequence, faeces accumulated in front of the stenotic segment,
distending the proximal innervated region (compare Fig. 7 A to B and
C). Thus, removal of one Zfhx1b allele in Sox10 heterozygous animals
results in more severe ENS defects that are neither compensated
during development nor after birth, and reduce the postnatal survival
drastically.
Discussion
Zfhx1b is co-expressed with Sox10 during ENS development and Sox10;
Zfhx1b double mutant mice studies reveal genetic interaction between
both genes exclusively during ENS development
If the expression and function of SOX10 are well established,
those of ZFHX1B remain elusive, and its interactions with otherTable 1
Genotypes distribution and viability analysis of animals resulting from Sox10LacZ/+ and Zfh








Pup mortality was quantiﬁed by identifying all animals post mortem or at weaning (numb
4 weeks or P0 and 6 weeks.ENS genes are unknown. Here, we show that Zfhx1b is present
with Sox10 at all phases of ENS development. Both transcription
factors are originally found in vagal neural crest cells migrating
towards the gut, and in undifferentiated ENCC precursor cells.
Later, their expression is maintained in GFAP-positive enteric glial
cells, but is switched off during neuronal differentiation. Indeed,
like SOX10, ZFHX1B is found in Mash1 positive cells (our
unpublished results), but is absent in neuronal cells that contain
TuJ1 or PGP9.5 markers ((Van de Putte et al., 2007) and this
study). This proﬁle contrasts sharply with the one described during
brain cortex development. Indeed, a recent study showed that
ZFHX1B protein is detected at the onset of cortical neurogenesis
where high levels are found in post-mitotic neurons, but
expression of this gene is barely detectable in progenitors
(Miquelajauregui et al., 2007; Seuntjens et al., 2009). Whether
these differences reﬂect diverse ZFHX1B functions and action
mechanisms remain to be elucidated.
Based on the Zfhx1b and Sox10 expression proﬁles, we speculated
that both factors could be jointly required for proper ENS develop-
ment. Through phenotype analysis of Sox10;Zfhx1b double mutants,
we show that a coordinated and balanced interaction between these
two genes is required for normal ENS development. Indeed, double
mutants present with more severe ENS defects highlighting a strong
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defects in double heterozygous mutant mice. With both genes already
being co-expressed in vagal neural crest cells before/at the time ENCC
enter the gut, we ﬁrst tested interaction at E9.5 and E10.5. In contrast
to Sox10;Sox8, Sox10;Edn3 and Sox10;Ednrb double mutants, we
noticed an apparent normal ENS development in Sox10;Zfhx1b
double heterozygous mutant embryos at these stages (Maka et al.,
2005; Stanchina et al., 2006), suggesting that interaction between
both factors only takes place when ENCC migrate along the gut.
To test this possibility, we analyzed the enteric phenotype of
embryos of different genotypes from E11.5 up to P5. Using several
markers, a dramatic reduction in the number of cells was seen in the
intestine of Sox10LacZ/+;Zfhx1bΔ/+ compared to single mutant
littermates. The wavefront of migrating ENCC appeared severely
delayed in all double heterozygous embryos and neonates that were
analyzed. The affected segment always extended beyond the ileo-
caecal junction, through the small intestine. We also examined the
postnatal survival of the animals, and found that the mortality rate of
70%, four weeks after birth, in Sox10LacZ/+;Zfhx1bΔ/+ clearly exceeds
the 8% observed in Sox10LacZ/+ animals on the same genetic
background. Thus, the ablation of one Zfhx1b allele in Sox10
heterozygous animals results in a more severe ENS phenotype from
E11.5 onwards. These defects can never be compensated for. Zfhx1b
therefore functions as a modiﬁer gene for Sox10-dependent ENS
defect as it increases both penetrance and severity of the defects in
Sox10 heterozygous mice despite having no detectable inﬂuence on
ENS development on its own. Whether such a genetic interaction
participates to the variability of Hirschsprung's disease phenotype
observed among patients presenting with SOX10 mutations remains
to be clariﬁed. However, these results highlight for the ﬁrst time an
interaction between two of the genes involved in syndromic forms of
Hirschsprung disease, i.e. Mowat–Wilson syndrome and Waarden-
burg syndrome type 4.
Both factors are also present in other neural crest derivatives such
as melanocytes, cranial ganglia, satellite glial cells and Schwann cells
of the peripheral nervous system (Britsch et al., 2001; Van de Putte et
al., 2007; Wegner, 2005). SOX10 and ZFHX1B are both present in
melanoblasts, and their complete removal appears deleterious for
melanocytes from the earlier stages of development (Van de Putte et
al., 2007; Wegner, 2005). Moreover, Sox10 and Zfhx1b null mouse
embryos present with severe defects of DRG and Schwann cell
development, highlighting an important function of both genes
during glial cell development. Based on these observations, we have
examined the formation and differentiation of these neural crest
derivatives in E10.5 and E11.5 Sox10LacZ/+;Zfhx1bΔ/+ embryos, but
found no obvious extra defects, suggesting a speciﬁc cooperative
requirement of both transcription factors in ENS development only.
Cellular origin of ENS defects observed in Sox10;Zfhx1b double
heterozygous embryos
To decipher the cellular bases of the defects observed, we analyzed
the proliferation, survival, and differentiation capacities of ENCC
within the intestine of embryos of various genotypes. We observed a
signiﬁcant decrease (of about 50%) in the number of Sox10-positive
progenitor cells in Sox10LacZ/+;Zfhx1bΔ/+ embryos compared to
controls. This reduction was not due to increased apoptosis, but
rather is caused by a signiﬁcant decrease (of about 50%) in their
proliferation capacities. We believe that this reduction of enteric
progenitor cells largely contributes to themore severe ENS phenotype
observed in the double heterozygous mutants.
We also checked whether the combined deletion of Sox10 and
Zfhx1b affect neuronal and/or glial differentiation, which could
explain the reduced migratory capacities of ENCC. We ﬁrst analyzed
overall neuronal differentiation, and observed a 15% increase in the
number of neurons in double mutants. This slight but signiﬁcantincrease could contribute to the more severe ENS defects observed in
Sox10LacZ/+;Zfhx1bΔ/+ mutants. More importantly, careful examina-
tion of neuronal markers revealed that terminal differentiationmaybe
speciﬁcally accelerated. Indeed, we observed a 38% increase in the
neuronal population presenting with “TuJ1-High” staining and long
axonal processes in Sox10LacZ/+;Zfhx1bΔ/+ compared to controls.
Interestingly, these results resemble those described upon homozy-
gous Zfhx1b deletion in the cortex. In the latter, the onset of
neurogenesis is not altered upon Zfhx1b conditional deletion.
However, once neurogenesis commences, the timing of production
of different cell types is shifted to earlier stages (Seuntjens et al.,
2009). This outcome is due to non-cell autonomous effects on
progenitor cells, as ZFHX1B protein is not expressed in progenitor
cells. In case of the ENS, we propose that the increase in neuronal
differentiation could be due to a secondary effect that is visible only
upon removal of one Zfhx1b allele in a Sox10 heterozygote
background. Alternatively, this increase in neuronal differentiation
could be due to a combined action of SOX10 and ZFHX1B on neuronal
differentiation, thus highlighting new cooperative functions of both
factors during ENS development, but future experiments are required
to test these possibilities.
In the brain cortex, the deletion of both Zfhx1b alleles also
increased gliogenesis. The premature end of neurogenesis may pave
the way for enhanced proliferation of glial precursors, which in turn
leads to the production of a higher number of astrocytes (Seuntjens et
al., 2009). We quantiﬁed the percentage of E13.5 ENCC speciﬁed to a
glial fate, but partial removal of Zfhx1b in Sox10 heterozygous does not
seem to affect the ENS glial differentiation process at the stages
observed.
Finally, partial loss of Sox10 and Zfhx1b alleles could directly affect
the migration of ENCC. A complete disorganization of the neuronal
network was clearly visible in colonized regions of Sox10LacZ/+;
Zfhx1bΔ/+ embryos. In line with these observations, it is important to
mention that BMPs control many aspects of ENS development,
including differentiation, proliferation, and survival of ENCC (Chala-
zonitis et al., 2004, 2008; De Santa Barbara et al., 2005). In addition,
activation of BMPs signaling reduces the rate of ENCC migration,
encourages ganglion cell aggregation, enhances neurite fasciculation,
controls radial migration within the bowel wall, and inﬂuences the
orientation of nerve ﬁbers within plexuses (Fu et al., 2006; Goldstein
et al., 2005). The clustering of ENCC and alteration of the pattern of
neurite extension observed upon treatment with BMP2 and BMP4 are
very similar to the network disorganization observed in this study (Fu
et al., 2006). Combined reduction of Sox10 and Zfhx1b levels could
therefore increase BMP activity (see below), and thus alter cell
migration/adhesion and neurite extension. This, of course does not
rule out that both factors have additional consecutive roles in ENS
development, which might be less sensitive to dosage effects.
Of note, ZFHX1B was also found in non-crest derived cells during
ENS development, i.e. in mesenchymal cells adjacent to the
epithelium ((Van de Putte et al., 2007) and this study), in a region
previously described as containing BMPs-expressing cells (Fu et al.,
2006). Interestingly, modulation of mesodermal BMP signaling
pathway in the hindgut affected all tissues layers: mesenchyme–
smooth muscle, ENS and endoderm–epithelium (De Santa Barbara et
al., 2005). This suggests that ZFHX1B could control ENS development
in both a cell autonomous and non-cell autonomous manner. We
therefore cannot exclude the possibility that this mesenchymal
Zfhx1b expression could be partly responsible for the phenotype
observed in double mutants.
Molecular origin of ENS defects observed in double heterozygous mutant
mice and implication for ENS formation
The Sox10/Zfhx1b interaction we detected here could be explained
by different molecular mechanisms. SOX10 could regulate Zfhx1b
427L. Stanchina et al. / Developmental Biology 341 (2010) 416–428transcription or vice versa; both of them could also act on
independent target genes that activate a common cascade; or act as
co-factors regulating the expression of common target genes in a
synergistic manner. Finally, both could be part of a common signaling
pathway, linked by indirect mechanisms. In order to gain insight into
these possibilities, we ﬁrst decided to analyze the effect of ZFHX1B on
Sox10 expression and vice versa. Several Sox10 enhancers were
recently described (Antonellis et al., 2006, 2008; Deal et al., 2006;
Dutton et al., 2008; Werner et al., 2007). Two of them seem essential
to drive Sox10 expression in ENS (Antonellis et al., 2008;Werner et al.,
2007). Interestingly, both sequences contain putative ZFHX1B binding
sites. Integrative genomic analysis of ZFHX1B was also very recently
carried out but no SOX binding sites were reported in the analyzed
regions (Katoh, 2009). Based on these observations, we used
luciferase assays and RT-PCR experiments to test i) the effect of
ZFHX1B on the two SOX10 regulatory sequences of interest and ii) the
effect of SOX10 overexpression on Zfhx1b expression, without success.
We cannot exclude that both transcription factors could act as co-
factors regulating the expression of common target genes in a
synergistic manner, but SOX proteins have to our knowledge not
been identiﬁed in the ZFHX1B proteome or picked-up in protein–
protein interactions screenings. With the data presently available, we
propose an indirect link, viamodulation of Bmp gene expression as the
molecular origin of the ENS defects observed. Kim et al. reported that
SOX10 preserves not only glial but – surprisingly – also neuronal
differentiation potential. The latter function is reﬂected in the
requirement of SOX10 in vivo and in vitro for induction of Mash1
and Phox2b. Simultaneously, SOX10 inhibits or delays neuronal
differentiation by repressing Phox2a. However, this activity requires
higher Sox10 gene dosage (Kim et al., 2003). In addition, application of
BMP ligand to NCC cultures caused SOX10 extinction within 24 hours.
Whether this action is direct or indirect, affects gene or protein levels
is not known, but these results clearly show that downregulation of
SOX10 is an early event in the rapid lineage restriction promoted by
BMP signaling (Kim et al., 2003). Independently, experiments
performed in Xenopus have shown that XSIP1 (ZFHX1B) is required
for inhibition of BMP signaling (van Grunsven et al., 2007): ZFHX1B
binds directly to the bmp4 promoter and represses its activity. If all
these regulations also take place during ENS development, we can
speculate that a reduction of ZFHX1B could lead to increased BMP
activity, which in turn could cause downregulation of SOX10. In the
context of Sox10 heterozygous animals, this extra reduction could be
critical and lead to increased Phox2a transcription (or of other
neuronal markers) and accelerated neuronal differentiation, thus
explaining part of the cellular defects observed in double mutants.
Although further work will be necessary to fully understand ZFHX1B
function during ENS throughout development and the molecular
origin of the ENS defects observed upon combined deletion of the
Sox10 and Zfhx1b alleles, the data presented here suggest that these
two transcription factors could work together to control ENS stem cell
maintenance and neuronal differentiation. Whether Zfhx1b interacts
with other ENS genes known to control ENS progenitor maintenance
remains to be tested. Interestingly, Seuntjens et al. suggested that
ZFHX1B could restrain the production of signaling factors produced in
post-mitotic neurons that feed back to progenitor cells to regulate the
timing of cell fate switch and the number of neurons and glial cells
(Seuntjens et al., 2009). In line with these observations, it would be
very interesting to test the possibility that ZFHX1B could control – or
be under the control of – signaling factors such as GDNF, or
endothelin-3, and thus control the pool size of ENCC and their
differentiation.
Taken altogether, our results contribute to improve our under-
standing of the cellular and genetic bases of the enteric defects
observed in mice and humans affected by SOX10 and ZFHX1B
mutations. They deﬁnitely further extend the molecular network
that governs proper ENS development.Acknowledgments
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